The 10 million new ordinary shares are allotted to Eddy Lee Yip Hang, who is the executive chairman and CEO of iX Biopharma.
iX Biopharma (SGX:42C
) announced that it has allotted and issued 10 million new ordinary shares at a price of six cents per warrant share as part of its exercise of warrants.
Following the exercise, the number of issued shares in iX Biopharma increased from 1,038,324,529 shares to 1,048,324,529 shares.
